Navigation Links
Pharsight Hosts European PKS User Meeting
Date:5/23/2008

Second Annual European Meeting to be Held In Paris

MOUNTAIN VIEW, Calif., May 23 /PRNewswire-FirstCall/ -- Pharsight Corporation (Nasdaq: PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, today announced that it will host its second Pharsight(R) Knowledgebase Server(TM) (PKS(TM)) European User Group Meeting on May 28 and 29, 2008 at the Hotel Concorde La Fayette, Paris, France.

The meeting provides an environment for industry scientists and developers to discuss challenges and advances in regulatory compliant PK/PD ("pharmacokinetic and pharmacodynamic") data management. Case studies will be presented by industry attendees to illustrate their use of PKS and the decisive impact the software has had on facilitating improved productivity in their drug development processes. More information is available by emailing info@pharsight.com.

"Our expanding European PKS user base has requested additional opportunities to meet and discuss developments in compliant, high-productivity PK/PD data management," said Shawn O'Connor, Pharsight president, CEO and chairman. "These meetings allow PKS users to benefit from the experience of their peers and allow Pharsight engineers to maintain close contact with our clientele."

About PKS

PKS is a high-productivity, regulatory-compliant enterprise data repository that manages clinical pharmacology data. PKS enables pharmaceutical and biotechnology companies to better manage and control preclinical and clinical PK/PD data and analyses, thus supporting higher modeling productivity as called for in the FDA's Critical Path Initiative. The FDA is using PKS under a Cooperative Research and Development Agreement (CRADA). Companies also use PKS to build PK/PD data management architecture that complies with the FDA's regulation 21 CFR Part 11, which has set new standards for computer system validation and usage. PKS is directly integrated with WinNonlin(R) Enterprise(TM), Pharsight's industry leading PK/PD modeling and analysis tool for state-of-the-art modeling and analyses, and supports direct access to any ODBC capable data source. PKS also supports analysis with leading tools such as NONMEM(R) and SAS(R).

About Pharsight Corporation

Pharsight Corporation develops and markets integrated products and services that enable pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products. Pharsight's goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products.

Pharsight's approach enhances the fundamental element of drug development success: strong decision-making. By adopting the Pharsight approach, customers acquire a new decision-making process with the potential to systematically improve every level and phase of their business and scientific processes. Pharsight Corporation is headquartered in Mountain View, California. Information about Pharsight is available at http://www.pharsight.com.

Registered Trademarks and Trademarks

Pharsight, Pharsight Knoweledgebase Server, PKS, WinNonlin, and WinNonlin Enterprise are trademarks or registered trademark of Pharsight Corporation. All other brand or product names mentioned in this document are trademarks or registered trademarks of their respective holders.


'/>"/>
SOURCE Pharsight Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Pharsight Achieves First License Sale for Public-Source Database
2. Pharsight to Present at ROeS Seminar in Bern, Switzerland on September 10 & 11, 2007
3. Pharsight Expands Strategic Consulting Services Team
4. Pharsight Hosts Fourth Annual PKS User Group Meeting
5. Pharsight Invited to Present on Winning Strategies for R&D Productivity at New York Pharma Forum on October 15, 2007
6. Pharsight Invited to Present on Oncology Modeling and Simulation at Quantitative Pharmacology Symposium in China
7. Pharsight Announces 1-For-3 Reverse Stock Split
8. Pharsight Signs Third WinNonlin(R) AutoPilot(TM) Customer
9. Pharsights Reporting and Analysis Services Business Reaches Quality Assurance Milestone
10. Pharsight Announces Fiscal Third Quarter 2008 Earnings Release Date and Conference Call
11. Pharsight Achieves $7.4 Million in Quarterly Revenue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... 2016  Biocom, the association for the California ... passage of 21 st Century Cures legislation in Congress. ... a 392-26 vote and in the Senate on December 7 ... Joe Panetta , president & CEO of Biocom: ... to millions of patients around the world. The measure culminates ...
(Date:12/7/2016)... Texas , Dec. 7, 2016  Genprex, ... of revolutionary immunogene therapy treatments, today announced that ... practice within a leading strategic communications and advisory ... communications program. The program will combine investor relations, ... objective of raising the profile of Genprex and ...
(Date:12/7/2016)... -- Regen BioPharma Inc. (OTCQB: RGBPP) In a ... a team of scientists in Guangzhou, China ... expression of NR2F6 in patients with early cervical cancer correlates ... cervical cancer tissue as well as in the normal tissue ... interesting study and the first that I am aware of ...
(Date:12/7/2016)... PA (PRWEB) , ... December 07, 2016 , ... ... website, http://www.autoreactors.com and online shopping cart. The new website has been ... functionality. These essential digital components allow customers to access detailed product information, read ...
Breaking Biology Technology:
(Date:11/30/2016)... Nov. 30, 2016 Not many of us realize that we spend ? ... so we need to do it well. Inadequate sleep levels have been found to ... stroke, diabetes, and even cancer. Maybe now is the best time to ... help them to manage their sleep quality? Continue Reading ... ...
(Date:11/29/2016)... -- Nearly one billion matches per second with DERMALOG,s high-speed ... ... DERMALOG is Germany's largest Multi-Biometric supplier: ... (PRNewsFoto/DERMALOG Identification Systems) ... is Germany's largest Multi-Biometric supplier: The company's Fingerprint Identification System is part ...
(Date:11/22/2016)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, is pleased to announce that the company has ... Sciences Awards as "Most Outstanding in eClinical Solutions" ... of recognition and growth for MedNet, which has effectively ... iMedNet ™ , MedNet,s flagship eClinical ...
Breaking Biology News(10 mins):